Avacta Group PLC
LSE:AVCT
Avacta Group PLC
PP&E Net
Avacta Group PLC
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Avacta Group PLC
LSE:AVCT
|
PP&E Net
£9m
|
CAGR 3-Years
49%
|
CAGR 5-Years
24%
|
CAGR 10-Years
27%
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
PP&E Net
$13m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
PP&E Net
$95.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
PP&E Net
$24.8m
|
CAGR 3-Years
58%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
PP&E Net
£42.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
PP&E Net
£509.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
See Also
What is Avacta Group PLC's PP&E Net?
PP&E Net
9m
GBP
Based on the financial report for Jun 30, 2023, Avacta Group PLC's PP&E Net amounts to 9m GBP.
What is Avacta Group PLC's PP&E Net growth rate?
PP&E Net CAGR 10Y
27%
Over the last year, the PP&E Net growth was 29%. The average annual PP&E Net growth rates for Avacta Group PLC have been 49% over the past three years , 24% over the past five years , and 27% over the past ten years .